Skip to content

Retrospective Analysis on Distal Humerus Fractures

Distal Humerus Fractures: A Data Analysis on Patients Undergoing Open Reduction and Internal Fixation for the Surgical Management of Distal Humeral Fractures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03637621
Acronym
(DHFx)
Enrollment
60
Registered
2018-08-20
Start date
2018-01-07
Completion date
2020-12-31
Last updated
2019-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Humerus Fracture

Brief summary

The purpose of this study is to evaluate preoperative objective measurements for distal humerus ORIF patients and operative objective measurements to determine if there is any effect to postoperative outcomes. Patients who were 18 years old or greater at the time of surgery were followed clinically and radiographically to determine best practice and optimal treatment and technique, risk and rate of complication, and postoperative outcomes.

Interventions

OTHERORIF

open reduction internal fixation of the distal humerus

Sponsors

The Orthopaedic Research & Innovation Foundation
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. English speaking 2. \>18 years of age 3. Open reduction internal fixation surgical management of a distal humeral fracture performed by principal investigator at St. Elizabeth Healthcare

Exclusion criteria

1. Non-English speaking 2. \<18 years of age

Design outcomes

Primary

MeasureTime frameDescription
total operative timepreoperative to up to 8 years postoperativeminutes
amount of blood losspreoperative to up to 8 years postoperativemls

Secondary

MeasureTime frameDescription
Patient Outcomespreoperative to up to 8 years postoperativeAmerican Shoulder and Elbow Surgeon score to measure shoulder function and pain. Scale of 0-100, 100 being the best possible score

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026